Sofinnova Partners appoints Karl Naegler as Partner
Seasoned investor with 20 years of experience and a strong track record strengthens VC’s leadership in early-stage life science investments
PARIS, France – September 10, 2024 — Sofinnova Partners (“Sofinnova”), a leading European venture capital firm in life sciences, based in Paris, London, and Milan, announced the appointment of Karl Naegler as Partner. This strategic hire also marks Sofinnova’s expansion into Germany, bolstering its reach and influence across Europe.
